Interventional Cardiology and Peripheral Vascular Devices Market Forecasts to 2021

1
MarketsandMarkets Presents
Interventional Cardiology and Peripheral Vascular
Devices Market worth 31.47 Billion USD by 2021
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
2
The report "Interventional Cardiology
Peripheral Vascular Devices Market (Angioplasty
Balloon, Stent, Catheters, EVAR Stent Grafts,
Abdominal Aortic Aneurysm, IVC Filter, Plaque
Modification, Hemodynamic Flow Alteration,
Accessories, Guidewire) - Forecasts to 2021", The
global interventional cardiology and peripheral
vascular devices market is expected to reach USD
31.47 Billion by 2021 from USD 21.83 Billion in
2016, at a CAGR of 7.1 from 2016 to
2021.    Browse 150 market data tables and 44
figures spread through 190 pages and in-depth TOC
on Interventional Cardiology Peripheral
Vascular Devices Market http//www.marketsandmarke
ts.com/Market-Reports/minimally-invasive-intervent
ional-cardiology-devices-market-548.html Early
buyers will receive 10 customization on This
report. Rising aging population, rising
incidence of cardiovascular diseases, increasing
demand of minimally invasive procedures, and
technological advancements are the major factors
driving the growth of this market.
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
3
On the basis of product, the interventional
cardiology market is segmented into angioplasty
balloons, angioplasty stents, catheters, EVAR
stent grafts, IVC filters, plaque modification
devices, hemodynamic flow alteration devices, and
accessories. The angioplasty stents segment
showcase high growth potential owing to
technological advancements, rising number of
regulatory approvals, and increasing investments
by companies to develop new devices. On the
basis of type, the angioplasty stents market is
segmented into drug-eluting stents, bare-metal
stents, and bioabsorbable stents. The
drug-eluting stents segment is projected to
witness the highest growth in this market due to
increasing number of regulatory approvals and new
product launches.
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
4
On the basis of type, the catheters market is
segmented into IVUS/OCT, angiography catheters,
and guiding catheters. The IVUS/OCT segment is
projected to witness the highest growth in this
market due to increasing penetration rates and
rapid advancements innovations in these
systems. The Sample Report For This Report_at_
http//www.marketsandmarkets.com/requestsample.as
p?id548 On the basis of type, the EVAR stent
grafts market is segmented into abdominal aortic
aneurysms and thoracic aortic aneurysms. The
abdominal aortic aneurysms segment is projected
to witness the highest growth in this market due
to rising incidence of smoking and hypertension.
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
5
Geographically, the interventional cardiology
market is dominated by North America, followed by
Europe, Asia, and the Rest of the World (RoW).
Growth in the North American region is primarily
driven by the rising incidence of cardiovascular
diseases, rapidly growing geriatric population,
and technological advancements. However, the
Asian market is projected to grow at the highest
CAGR during the forecast period. Get The PDF
Brochure For This Report_at_ http//www.marketsandmar
kets.com/pdfdownload.asp?id548 Key players
operating in the interventional cardiology market
include Abbott Laboratories (U.S.), Boston
Scientific Corporation (U.S.), B. Braun Melsungen
AG (Germany), Cordis Corporation (U.S.), C.R.
Bard, Inc. (U.S.), Medtronic plc (U.S.), and
Terumo Corporation (Japan).
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/mi
nimally-invasive-interventional-cardiology-devices
-market-548.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets